AAAAAA

   
Results: 1-18 |
Results: 18
DETERMINATION OF CLOZAPINE, DESMETHYLCLOZAPINE AND CLOZAPINE N-OXIDE IN HUMAN PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION
Authors: AVENOSO A FACCIOLA G CAMPO GM FAZIO A SPINA E
Citation: A. Avenoso et al., DETERMINATION OF CLOZAPINE, DESMETHYLCLOZAPINE AND CLOZAPINE N-OXIDE IN HUMAN PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography B. Biomedical sciences and applications, 714(2), 1998, pp. 299-308
NO EFFECT OF CITALOPRAM ON PLASMA-LEVELS OF CLOZAPINE, RISPERIDONE AND THEIR ACTIVE METABOLITES IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA
Authors: AVENOSO A FACCIOLA G SCORDO MG GITTO C FERRANTE GD MADIA AG SPINA E
Citation: A. Avenoso et al., NO EFFECT OF CITALOPRAM ON PLASMA-LEVELS OF CLOZAPINE, RISPERIDONE AND THEIR ACTIVE METABOLITES IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA, Clinical drug investigation, 16(5), 1998, pp. 393-398
EFFECT OF FLUOXETINE ON THE PLASMA-CONCENTRATIONS OF CLOZAPINE AND ITS MAJOR METABOLITES IN PATIENTS WITH SCHIZOPHRENIA
Authors: SPINA E AVENOSO A FACCIOLA G FABRAZZO M MONTELEONE P MAJ M PERUCCA E CAPUTI AP
Citation: E. Spina et al., EFFECT OF FLUOXETINE ON THE PLASMA-CONCENTRATIONS OF CLOZAPINE AND ITS MAJOR METABOLITES IN PATIENTS WITH SCHIZOPHRENIA, International clinical psychopharmacology, 13(3), 1998, pp. 141-145
INDUCING EFFECT OF PHENOBARBITAL ON CLOZAPINE METABOLISM IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA
Authors: FACCIOLA G AVENOSO A SPINA E PERUCCA E
Citation: G. Facciola et al., INDUCING EFFECT OF PHENOBARBITAL ON CLOZAPINE METABOLISM IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA, Therapeutic drug monitoring, 20(6), 1998, pp. 628-630
ISSUES IN METHODOLOGY AND APPLICATIONS FOR THERAPEUTIC DRUG-MONITORING OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS
Authors: ZUCCARO P PACIFICI R ALTIERI I AVENOSO A PELLEGRINI M SPINA E PERUCCA E PICHINI S
Citation: P. Zuccaro et al., ISSUES IN METHODOLOGY AND APPLICATIONS FOR THERAPEUTIC DRUG-MONITORING OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS, Therapeutic drug monitoring, 20(1), 1998, pp. 20-24
BENEFICIAL EFFECT OF RAXOFELAST, AN HYDROPHILIC VITAMIN-E ANALOG, IN THE RAT-HEART AFTER ISCHEMIA AND REPERFUSION INJURY
Authors: CAMPO GM SQUADRITO F CAMPO S ALTAVILLA D QUARTARONE C CECCARELLI S FERLITO M AVENOSO A SQUADRITO G SAITTA A CAPUTI AP
Citation: Gm. Campo et al., BENEFICIAL EFFECT OF RAXOFELAST, AN HYDROPHILIC VITAMIN-E ANALOG, IN THE RAT-HEART AFTER ISCHEMIA AND REPERFUSION INJURY, Journal of Molecular and Cellular Cardiology, 30(8), 1998, pp. 1493-1503
ANTIOXIDANT ACTIVITY OF U-83836E, A 2ND-GENERATION LAZAROID, DURING MYOCARDIAL ISCHEMIA REPERFUSION INJURY/
Authors: CAMPO GM SQUADRITO F CAMPO S ALTAVILLA D AVENOSO A FERLITO M SQUADRITO G CAPUTI AP
Citation: Gm. Campo et al., ANTIOXIDANT ACTIVITY OF U-83836E, A 2ND-GENERATION LAZAROID, DURING MYOCARDIAL ISCHEMIA REPERFUSION INJURY/, Free radical research, 27(6), 1997, pp. 577-590
INTERACTION BETWEEN FLUOXETINE AND HALOPERIDOL - PHARMACOKINETIC AND CLINICAL IMPLICATIONS
Authors: AVENOSO A SPINA E CAMPO G FACCIOLA G FERLITO M ZUCCARO P PERUCCA E CAPUTI AP
Citation: A. Avenoso et al., INTERACTION BETWEEN FLUOXETINE AND HALOPERIDOL - PHARMACOKINETIC AND CLINICAL IMPLICATIONS, Pharmacological research, 35(4), 1997, pp. 335-339
EFFECT OF KETOCONAZOLE ON THE PHARMACOKINETICS OF IMIPRAMINE AND DESIPRAMINE IN HEALTHY-SUBJECTS
Authors: SPINA E AVENOSO A CAMPO GM SCORDO MG CAPUTI AP PERUCCA E
Citation: E. Spina et al., EFFECT OF KETOCONAZOLE ON THE PHARMACOKINETICS OF IMIPRAMINE AND DESIPRAMINE IN HEALTHY-SUBJECTS, British journal of clinical pharmacology, 43(3), 1997, pp. 315-318
RELATIONSHIP BETWEEN PLASMA DESIPRAMINE LEVELS, CYP2D6 PHENOTYPE AND CLINICAL-RESPONSE TO DESIPRAMINE - A PROSPECTIVE-STUDY
Authors: SPINA E GITTO C AVENOSO A CAMPO GM CAPUTI AP PERUCCA E
Citation: E. Spina et al., RELATIONSHIP BETWEEN PLASMA DESIPRAMINE LEVELS, CYP2D6 PHENOTYPE AND CLINICAL-RESPONSE TO DESIPRAMINE - A PROSPECTIVE-STUDY, European Journal of Clinical Pharmacology, 51(5), 1997, pp. 395-398
PHENOBARBITAL INDUCES THE 2-HYDROXYLATION OF DESIPRAMINE
Authors: SPINA E AVENOSO A CAMPO GM CAPUTI AP PERUCCA E
Citation: E. Spina et al., PHENOBARBITAL INDUCES THE 2-HYDROXYLATION OF DESIPRAMINE, Therapeutic drug monitoring, 18(1), 1996, pp. 60-64
PROTECTION OF ISCHEMIC AND REPERFUSED RAT MYOCARDIUM BY THE NONGLUCOCORTICOID 21-AMINOSTEROID U-74389G, A NEW INHIBITOR OF LIPID-PEROXIDATION
Authors: CAMPO GM SQUADRITO F ALTAVILLA D SQUADRITO G AVENOSO A CANALE P IOCULANO M SPERANDEO A CAPUTI AP
Citation: Gm. Campo et al., PROTECTION OF ISCHEMIC AND REPERFUSED RAT MYOCARDIUM BY THE NONGLUCOCORTICOID 21-AMINOSTEROID U-74389G, A NEW INHIBITOR OF LIPID-PEROXIDATION, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 333-340
THE EFFECT OF CARBAMAZEPINE ON THE 2-HYDROXYLATION OF DESIPRAMINE
Authors: SPINA E AVENOSO A CAMPO GM CAPUTI AP PERUCCA E
Citation: E. Spina et al., THE EFFECT OF CARBAMAZEPINE ON THE 2-HYDROXYLATION OF DESIPRAMINE, Psychopharmacology, 117(4), 1995, pp. 413-416
CYP2D6-RELATED OXIDATION POLYMORPHISM IN ITALY
Authors: SPINA E CAMPO GM AVENOSO A CAPUTI AP ZUCCARO P PACIFICI R GATTI G STRADA G BARTOLI A PERUCCA E
Citation: E. Spina et al., CYP2D6-RELATED OXIDATION POLYMORPHISM IN ITALY, Pharmacological research, 29(3), 1994, pp. 281-289
DECREASED PLASMA-CONCENTRATIONS OF IMIPRAMINE AND DESIPRAMINE FOLLOWING CHOLESTYRAMINE INTAKE IN DEPRESSED-PATIENTS
Authors: SPINA E AVENOSO A CAMPO GM CAPUTI AP PERUCCA E
Citation: E. Spina et al., DECREASED PLASMA-CONCENTRATIONS OF IMIPRAMINE AND DESIPRAMINE FOLLOWING CHOLESTYRAMINE INTAKE IN DEPRESSED-PATIENTS, Therapeutic drug monitoring, 16(4), 1994, pp. 432-434
FLUVOXAMINE-INDUCED ALTERATIONS IN PLASMA-CONCENTRATIONS OF IMIPRAMINE AND DESIPRAMINE IN DEPRESSED-PATIENTS
Authors: SPINA E POLLICINO AM AVENOSO A CAMPO GM CAPUTI AP
Citation: E. Spina et al., FLUVOXAMINE-INDUCED ALTERATIONS IN PLASMA-CONCENTRATIONS OF IMIPRAMINE AND DESIPRAMINE IN DEPRESSED-PATIENTS, International journal of clinical pharmacology research, 13(3), 1993, pp. 167-171
EFFECT OF FLUVOXAMINE ON THE PHARMACOKINETICS OF IMIPRAMINE AND DESIPRAMINE IN HEALTHY-SUBJECTS
Authors: SPINA E POLLICINO AM AVENOSO A CAMPO GM PERUCCA E CAPUTI AP
Citation: E. Spina et al., EFFECT OF FLUVOXAMINE ON THE PHARMACOKINETICS OF IMIPRAMINE AND DESIPRAMINE IN HEALTHY-SUBJECTS, Therapeutic drug monitoring, 15(3), 1993, pp. 243-246
CARBAMAZEPINE COADMINISTRATION WITH FLUOXETINE OR FLUVOXAMINE
Authors: SPINA E AVENOSO A POLLICINO AM CAPUTI AP FAZIO A PISANI F
Citation: E. Spina et al., CARBAMAZEPINE COADMINISTRATION WITH FLUOXETINE OR FLUVOXAMINE, Therapeutic drug monitoring, 15(3), 1993, pp. 247-250
Risultati: 1-18 |